s6y

Alzamend Neuro, Inc.

Ticker
ALZN
CIK
1677077
Industry
Pharmaceutical Preparations

Financials 34

  1. 10-Q Quarterly Report for period ending Jul 31, 2026
  2. 10-K Annual Report for period ending Apr 30, 2026
  3. 10-Q Quarterly Report for period ending Jan 31, 2026
  4. 10-Q Quarterly Report for period ending Oct 31, 2025
  5. 10-Q Quarterly Report for period ending Jul 31, 2025
  6. 10-K Annual Report for period ending Apr 30, 2025
  7. 10-Q Quarterly Report for period ending Jan 31, 2025
  8. 10-Q Quarterly Report for period ending Oct 31, 2024
  9. 10-Q Quarterly Report for period ending Jul 31, 2024
  10. 10-K Annual Report for period ending Apr 30, 2024

All 34 financials filings

News 84

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K/A Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 84 news filings

Ownership 176

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4/A Statement of changes in beneficial ownership of securities
  3. 4/A Statement of changes in beneficial ownership of securities
  4. 4/A Statement of changes in beneficial ownership of securities
  5. 3/A Initial statement of beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 5 Annual statement of changes in beneficial ownership of securities
  10. 5 Annual statement of changes in beneficial ownership of securities

All 176 ownership filings

Prospectus 40

  1. S-3 Registration statement for specified transactions by certain issuers
  2. RW Registration Withdrawal Request
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. S-1/A General form of registration statement for all companies including face-amount certificate companies
  7. S-3 Registration statement for specified transactions by certain issuers
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. S-1/A General form of registration statement for all companies including face-amount certificate companies

All 40 prospectus filings

Proxies 18

  1. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 18 proxies filings

Other 49

  1. SCHEDULE 13D/A
  2. SCHEDULE 13D/A
  3. SCHEDULE 13D/A
  4. SCHEDULE 13D/A
  5. SCHEDULE 13D/A
  6. SCHEDULE 13D/A
  7. 144/A Filing for proposed sale of securities under Rule 144
  8. 144 Filing for proposed sale of securities under Rule 144
  9. EFFECT Notice of Effectiveness
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 49 other filings